Article
In vivo activation of the PI3K-Akt pathway in mouse beta cells by the EGFR mutation L858R protects against diabetes.
Diabetologia - 1 May 2014
Hakonen Elina, Ustinov Jarkko, Eizirik Décio L, Sariola Hannu, Miettinen Päivi J, Otonkoski Timo
Abstract excerpt
AIMS/HYPOTHESIS: EGF receptor (EGFR) signalling is required for normal beta cell development and postnatal beta cell proliferation. We tested whether beta cell proliferation can be triggered by EGFR activation at any age and whether this can protect beta cells against apoptosis induced by diabetogenic insults in a mouse model. METHODS: We generated transgenic mice with doxycycline-inducible expression of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
